MustGrow Biologics Corp. (TSXV:MGRO)

Market Cap	37.78M -52.7%
Revenue (ttm)	7.54M +51.0%
Net Income	-6.37M
EPS	-0.12
Shares Out	62.96M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	126,900
Average Volume	139,719
Open	0.6000
Previous Close	0.5900
Day's Range	0.6000 - 0.6000
52-Week Range	0.5000 - 1.4500
Beta	0.67
RSI	39.12
Earnings Date	Apr 23, 2026

About MustGrow Biologics

MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard plants. The company provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home and garden markets, as well as agriculture markets where glyphosate has been banned; and suppress sprouting, and treat disease and pathogen for storage...

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 2014
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: MGRO

Financial Performance

In 2024, MustGrow Biologics's revenue was 398,018, a decrease of -91.55% compared to the previous year's 4.71 million. Losses were -4.89 million, 622.2% more than in 2023.